(Bi-)Ulnar Access for Percutaneous Intervention of Coronary Chronic Total Occlusion: A Case Series.


Journal

Cardiovascular revascularization medicine : including molecular interventions
ISSN: 1878-0938
Titre abrégé: Cardiovasc Revasc Med
Pays: United States
ID NLM: 101238551

Informations de publication

Date de publication:
11 2020
Historique:
received: 11 08 2019
revised: 02 10 2019
accepted: 09 10 2019
pubmed: 26 11 2019
medline: 13 8 2021
entrez: 26 11 2019
Statut: ppublish

Résumé

Percutaneous Coronary Interventions (PCI) of chronic total occlusions (CTOs) represent one of the most complex procedure in the whole spectrum of PCI. In the last years the success rate of CTO-PCI has improved because of the evolution in materials and in CTO-techniques. For most CTO operators, the choice of the vascular access has been driven by the desire to achieve a high success-rate. The trans-femoral access allows the use of larger caliber guide catheters with increased passive support and may help to achieve a better procedural success. Recently, the use of bi-radial approach has gained popularity, supported by evidence of non-inferiority versus the bifemoral/radial-femoral approach. At present, very limited data are available concerning the use of trans-ulnar access for this complex setting of PCI. In the present manuscript, we describe in detail a case series of patients undergoing CTO PCI, with limited options in vascular access and resolved with trans-ulnar approach. Our case series shows the safety and feasibility of transulnar approach in CTO-PCI.

Sections du résumé

BACKGROUND
Percutaneous Coronary Interventions (PCI) of chronic total occlusions (CTOs) represent one of the most complex procedure in the whole spectrum of PCI. In the last years the success rate of CTO-PCI has improved because of the evolution in materials and in CTO-techniques. For most CTO operators, the choice of the vascular access has been driven by the desire to achieve a high success-rate. The trans-femoral access allows the use of larger caliber guide catheters with increased passive support and may help to achieve a better procedural success. Recently, the use of bi-radial approach has gained popularity, supported by evidence of non-inferiority versus the bifemoral/radial-femoral approach. At present, very limited data are available concerning the use of trans-ulnar access for this complex setting of PCI.
CASE PRESENTATION
In the present manuscript, we describe in detail a case series of patients undergoing CTO PCI, with limited options in vascular access and resolved with trans-ulnar approach.
CONCLUSIONS
Our case series shows the safety and feasibility of transulnar approach in CTO-PCI.

Identifiants

pubmed: 31761639
pii: S1553-8389(19)30667-0
doi: 10.1016/j.carrev.2019.10.014
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

130-133

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Simone Budassi wrote the case series, Carlo Zivelonghi gave his contribution during the drafting of the text, Benjamin Scott reviewed it critically for important intellectual content, Pierfrancesco Agostoni gave important ideas and reviewed critically all the manuscript. The authors declare that there is no conflict of interest.

Auteurs

Simone Budassi (S)

HartCentrum Ziekenhuis Netwerk Antwerpen (ZNA) Middelheim, Antwerp, Belgium; Cardiology and Interventional Cardiology Department, Policlinico Tor Vergata, Rome, Italy.

Carlo Zivelonghi (C)

HartCentrum Ziekenhuis Netwerk Antwerpen (ZNA) Middelheim, Antwerp, Belgium.

Benjamin Scott (B)

HartCentrum Ziekenhuis Netwerk Antwerpen (ZNA) Middelheim, Antwerp, Belgium.

Pierfrancesco Agostoni (P)

HartCentrum Ziekenhuis Netwerk Antwerpen (ZNA) Middelheim, Antwerp, Belgium. Electronic address: agostonipf@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH